Beleave Inc. (BLEVF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Beleave Inc. (BLEVF) trades at $0.00 with AI Score 44/100 (Grade C). Beleave Inc. is a Canadian medical cannabis company involved in cultivation, sales, and clinic operations. The company faces challenges in a competitive market with a negative profit margin. Market cap: $566, Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for BLEVF: BLEVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BLEVF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BLEVF: the 1 perspectives are evenly split.
How is this calculated? →Beleave Inc. (BLEVF) Healthcare & Pipeline Overview
Beleave Inc., based in Canada, cultivates and sells medical and recreational cannabis, operating Medi-Green clinics in Ontario and Quebec. With a negative profit margin of -1423.0% and trading on the OTC market, the company navigates a competitive landscape against peers like ACGJ and ARTH.
What Is the Investment Thesis for BLEVF?
Investing in Beleave Inc. (BLEVF) presents a speculative opportunity within the Canadian cannabis market. Key value drivers include the potential expansion of its Medi-Green clinic network and increased sales of recreational cannabis products. However, the company's negative profit margin of -1423.0% raises concerns about its financial sustainability. Growth catalysts include potential regulatory changes that could expand market access and increased consumer demand for cannabis products. The company's high beta of -148.45 indicates extreme volatility relative to the market. The investment thesis hinges on Beleave's ability to improve its operational efficiency, reduce costs, and achieve profitability in a highly competitive environment. Investors should carefully consider the risks associated with investing in a company with a history of financial losses and significant market volatility.
Based on FMP financials and quantitative analysis
BLEVF Key Highlights
- Negative Profit Margin: Beleave Inc. has a profit margin of -1423.0%, indicating significant losses relative to revenue.
- Gross Margin: The company's gross margin is 34.4%, suggesting some efficiency in production costs before accounting for operating expenses.
- Market Cap: Beleave Inc.'s market capitalization is $0.00B, reflecting its small size and potential risks.
- P/E Ratio: The company's P/E ratio is -0.00, which is not meaningful due to negative earnings.
- Beta: Beleave Inc. has a beta of -148.45, indicating extreme volatility and a negative correlation with the market.
Who Are BLEVF's Competitors?
BLEVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BLEVF's Key Strengths?
- Established network of medical cannabis clinics.
- Integrated business model.
- Brand recognition in the Canadian market.
What Are BLEVF's Weaknesses?
- Negative profit margin.
- High beta indicating extreme volatility.
- Small market capitalization.
What Could Drive BLEVF Stock Higher?
- Potential regulatory changes that could expand market access for cannabis products.
- Increasing consumer demand for cannabis products.
- Expansion of the Medi-Green clinic network.
What Are the Key Risks for BLEVF?
- Financial-distress signal — its Altman Z-Score of -5.63 sits in the distress zone (elevated bankruptcy risk).
- Intense competition in the Canadian cannabis market.
- Fluctuations in cannabis prices.
- Evolving regulations.
- Negative profit margin and financial losses.
- Low liquidity due to OTC market trading.
What Are the Growth Opportunities for BLEVF?
- Expansion of Medi-Green Clinic Network: Beleave Inc. can expand its network of Medi-Green medical cannabis clinics in Ontario and Quebec. The market for medical cannabis is growing, driven by increasing awareness of its therapeutic benefits and the aging population. Expanding the clinic network would provide Beleave with a direct channel to patients, allowing it to offer personalized care and build brand loyalty. The timeline for expansion depends on regulatory approvals and capital availability, but represents a significant growth opportunity in the coming years.
- Increased Sales of Recreational Cannabis Products: Beleave Inc. can increase its sales of recreational cannabis products through its retail stores and online platform. The recreational cannabis market is larger than the medical cannabis market, offering significant growth potential. To capitalize on this opportunity, Beleave needs to develop innovative products, enhance its marketing efforts, and expand its distribution network. The timeline for achieving significant growth in recreational cannabis sales is dependent on market trends and competitive dynamics.
- Development of New Cannabis Products: Beleave Inc. can develop new cannabis products to meet evolving consumer preferences. The market for cannabis products is constantly evolving, with new products and consumption methods emerging regularly. By investing in research and development, Beleave can create innovative products that appeal to a wider range of consumers. The timeline for developing and launching new products depends on regulatory approvals and market demand, but represents a long-term growth opportunity.
- Strategic Partnerships and Acquisitions: Beleave Inc. can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. The cannabis industry is consolidating, with larger companies acquiring smaller players to gain access to new markets and technologies. By partnering with other companies or acquiring complementary businesses, Beleave can accelerate its growth and enhance its competitive position. The timeline for pursuing strategic partnerships and acquisitions depends on market conditions and available opportunities.
- International Expansion: Beleave Inc. can explore opportunities for international expansion, particularly in countries where cannabis is legal or becoming legal. The global cannabis market is growing rapidly, offering significant growth potential for companies that can successfully navigate international regulations and market dynamics. Expanding into new markets would diversify Beleave's revenue streams and reduce its reliance on the Canadian market. The timeline for international expansion depends on regulatory changes and market opportunities in other countries.
What Opportunities Does BLEVF Have?
- Expansion of clinic network.
- Increased sales of recreational cannabis products.
- Development of new cannabis products.
What Threats Does BLEVF Face?
- Intense competition in the Canadian cannabis market.
- Evolving regulations.
- Fluctuations in cannabis prices.
What Are BLEVF's Competitive Advantages?
- Established network of Medi-Green medical cannabis clinics.
- Integrated business model encompassing cultivation, retail, and clinic operations.
- Brand recognition in the Canadian cannabis market.
What Does BLEVF Do?
Beleave Inc. was founded to participate in the burgeoning Canadian cannabis market, focusing on both medical and recreational applications. The company cultivates cannabis and manufactures related products, selling them through its own retail stores and online platforms. Additionally, Beleave operates a network of medical cannabis clinics under the Medi-Green banner in Ontario and Quebec, providing patient access and education. The company's business model integrates cultivation, product development, retail, and clinic operations to serve a broad spectrum of cannabis consumers and patients. Beleave Inc. is headquartered in Oakville, Canada, and has sought to establish a presence across the Canadian market. However, the company faces challenges in achieving profitability, as reflected in its significant negative profit margin. Beleave competes with other cannabis producers and retailers, striving to differentiate itself through product quality, clinic services, and brand recognition. The company's strategy involves expanding its product offerings and clinic network to capture a larger share of the Canadian cannabis market. Beleave aims to capitalize on the growing acceptance and legalization of cannabis in Canada, while navigating regulatory complexities and competitive pressures.
What Products and Services Does BLEVF Offer?
- Cultivates medical and recreational cannabis.
- Sells cannabis products through retail stores.
- Operates an online platform for cannabis sales.
- Manages a network of medical cannabis clinics under the Medi-Green banner.
- Provides patient access and education through its clinics.
- Manufactures cannabis-related products.
How Does BLEVF Make Money?
- Cultivating cannabis and processing it into various products.
- Selling cannabis products directly to consumers through retail stores and online.
- Generating revenue from patient consultations and cannabis prescriptions through Medi-Green clinics.
What Industry Does BLEVF Operate In?
Beleave Inc. operates within the Canadian cannabis industry, which has experienced rapid growth and increasing competition since legalization. The market is characterized by evolving regulations, shifting consumer preferences, and the emergence of numerous players vying for market share. Companies like Beleave face the challenge of differentiating themselves in a crowded market while navigating complex regulatory frameworks. The industry is also subject to fluctuations in cannabis prices and changing consumer demand patterns. Beleave competes with larger, more established cannabis companies, as well as smaller, niche players. The company's success depends on its ability to innovate, execute its business strategy effectively, and adapt to the dynamic market environment.
Who Are BLEVF's Key Customers?
- Medical cannabis patients seeking therapeutic relief.
- Recreational cannabis consumers.
- Individuals seeking cannabis-related information and education.
F-Score 4/9Financial Health
Beleave Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -5.63 places it in the distress zone, a signal of elevated financial risk.
Beleave Inc. (BLEVF) Valuation Context
Valued at 566, BLEVF is classified as a micro-cap stock. Relative to its peer group, BLEVF's quantitative score of 44/100 is below the peer average of 66/100.
Company Profile
Beleave Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Oakville, CA. The company is led by CEO Vasilios Panagiotakopoulos. BLEVF has traded publicly since 2016.
BLEVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established network of medical cannabis clinics.
- Integrated business model.
- Brand recognition in the Canadian market.
- Upcoming: Potential regulatory changes that could expand market access for cannabis products.
Bear Case
- Negative profit margin.
- High beta indicating extreme volatility.
- Small market capitalization.
- Ongoing: Intense competition in the Canadian cannabis market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
BLEVF Latest News
No recent news available for BLEVF.
BLEVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BLEVF.
Price Targets
Wall Street price target analysis for BLEVF.
BLEVF MoonshotScore
What does this score mean?
The MoonshotScore rates BLEVF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Vasilios Panagiotakopoulos
CEO
Vasilios Panagiotakopoulos serves as the CEO of Beleave Inc. His background and experience prior to joining Beleave are not detailed in the provided data. As CEO, he is responsible for overseeing the company's operations, strategic direction, and financial performance. His leadership is crucial for navigating the competitive Canadian cannabis market and achieving the company's growth objectives.
Track Record: Due to limitations in the provided data, it is not possible to assess Vasilios Panagiotakopoulos's specific achievements or strategic decisions as CEO of Beleave Inc. His track record and the company's milestones under his leadership are currently unknown.
BLEVF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Beleave Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may be subject to greater risks due to less stringent listing requirements. Investing in companies on the OTC Other tier requires careful due diligence and a thorough understanding of the associated risks, as these companies may not be subject to the same regulatory oversight as those listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement compared to listed companies.
- Limited regulatory oversight.
- Verify the company's registration and legal standing.
- Obtain and review available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and ownership.
- Assess the liquidity and trading volume of the stock.
- Consult with a qualified financial advisor.
- Operation of Medi-Green medical cannabis clinics.
- Cultivation and sale of cannabis products.
- Presence in the Canadian cannabis market.
What Investors Ask About Beleave Inc. (BLEVF) — Healthcare
What does Beleave Inc. do?
Beleave Inc. operates as a medical cannabis company in Canada. It cultivates and sells both medical and recreational cannabis products through its own retail stores and online platform. Additionally, the company operates a network of medical cannabis clinics under the Medi-Green banner in Ontario and Quebec. These clinics provide patients with access to medical cannabis prescriptions and related services, integrating cultivation, product development, retail, and clinic operations to serve a broad spectrum of cannabis consumers and patients.
What do analysts say about BLEVF stock?
Due to the limited information available and the company's OTC listing, there is no readily available analyst coverage or consensus on BLEVF stock. Investors should conduct their own thorough research and due diligence before making any investment decisions. Key valuation metrics, such as price targets and earnings estimates, are not available from traditional analyst sources. The company's growth prospects and financial performance should be carefully evaluated based on its publicly available information and industry trends.
What are the main risks for BLEVF?
Beleave Inc. faces several risks, including intense competition in the Canadian cannabis market, evolving regulations, and fluctuations in cannabis prices. The company's negative profit margin and financial losses pose a significant risk to its long-term sustainability. As an OTC-listed stock, BLEVF is subject to lower liquidity and higher volatility compared to stocks listed on major exchanges. Investors should carefully consider these risks before investing in Beleave Inc.
What are the key factors to evaluate for BLEVF?
Beleave Inc. (BLEVF) holds an AI score of 44/100 (low). Not financial advice.
How frequently does BLEVF data refresh on this page?
BLEVF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven BLEVF's recent stock price performance?
Beleave Inc. (BLEVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of medical cannabis clinics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BLEVF overvalued or undervalued right now?
Valuing Beleave Inc. (BLEVF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying BLEVF?
Before investing in Beleave Inc. (BLEVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial information available for Beleave Inc.
- Lack of analyst coverage for BLEVF stock.
- OTC listing indicates higher risk and lower liquidity.